Eur Respir J 2004; 24:822-833 Copyright ©ERS Journals Ltd 2004 doi: 10.1183/09031936.04.00039004
Asthma and cigarette smoking
N.C. Thomson,
R. Chaudhuri and
E. Livingston
Dept of Respiratory Medicine, Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, UK.
CORRESPONDENCE: N.C. Thomson, Dept of Respiratory Medicine, Division of Immunology, Infection and Inflammation, Western Infirmary & University of Glasgow, Glasgow, G11 6NT, UK. Fax: 44 1412113464. E-mail: n.c.thomson@clinmed.gla.ac.uk
Keywords: Asthma, corticosteroid resistance, smokers, smoking cessation
Received: April 1, 2004
Accepted July 6, 2004
Abstract
In most developed countries 25% of adults with asthma are current cigarette smokers. Asthma and active cigarette smoking interact to cause more severe symptoms, accelerated decline in lung function, and impaired short-term therapeutic response to corticosteroids.
Cigarette smoking may modify inflammation that is associated with asthma, although there is limited published data on airway pathology in smokers with asthma. To date, the evidence points towards a combination of both heightened and suppressed inflammatory responses in smokers compared with nonsmokers with asthma.
The mechanisms of corticosteroid resistance in asthmatic smokers are unexplained, but could be as a result of alterations in airway inflammatory cell phenotypes (e.g. increased neutrophils or reduced eosinophils), changes in the glucocorticoid receptor- to -ß ratio (e.g. overexpression of glucocorticoid receptor ß), and increased activation of pro-inflammatory transcription factors (e.g. nuclear factor- B) or reduced histone deacetylase activity.
In conclusion, every effort should be made to encourage asthmatics who smoke to stop, although the effects of smoking cessation upon reversing the adverse effects of tobacco smoke on asthma control, therapeutic response to corticosteroids and airway pathology have yet to be fully elucidated. Alternative or additional therapies to inhaled corticosteroids are needed for asthmatic patients who are unable to quit smoking.
This article has been cited by other articles:

|
 |

|
 |
 
M. Broekema, N. H. T. ten Hacken, F. Volbeda, M. E. Lodewijk, M. N. Hylkema, D. S. Postma, and W. Timens
Airway Epithelial Changes in Smokers but Not in Ex-Smokers with Asthma
Am. J. Respir. Crit. Care Med.,
December 15, 2009;
180(12):
1170 - 1178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Bossley, S. Saglani, C. Kavanagh, D. N. R. Payne, N. Wilson, L. Tsartsali, M. Rosenthal, I. M. Balfour-Lynn, A. G. Nicholson, and A. Bush
Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma
Eur. Respir. J.,
November 1, 2009;
34(5):
1052 - 1059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Robays, E. A. Lanckacker, K. B. Moerloose, T. Maes, K. R. Bracke, G. G. Brusselle, G. F. Joos, and K. Y. Vermaelen
Concomitant Inhalation of Cigarette Smoke and Aerosolized Protein Activates Airway Dendritic Cells and Induces Allergic Airway Inflammation in a TLR-Independent Way
J. Immunol.,
August 15, 2009;
183(4):
2758 - 2766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Singh, N. C. Mishra, J. Rir-sima-ah, M. Campen, V. Kurup, S. Razani-Boroujerdi, and M. L. Sopori
Maternal Exposure to Secondhand Cigarette Smoke Primes the Lung for Induction of Phosphodiesterase-4D5 Isozyme and Exacerbated Th2 Responses: Rolipram Attenuates the Airway Hyperreactivity and Muscarinic Receptor Expression but Not Lung Inflammation and Atopy
J. Immunol.,
August 1, 2009;
183(3):
2115 - 2121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Michils, R. Louis, R. Peche, S. Baldassarre, and A. Van Muylem
Exhaled nitric oxide as a marker of asthma control in smoking patients
Eur. Respir. J.,
June 1, 2009;
33(6):
1295 - 1301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Quaak, C. P. van Schayck, A. M. Knaapen, and F. J. van Schooten
Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?
Eur. Respir. J.,
March 1, 2009;
33(3):
468 - 480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O. M. Van De Ven, R. C. M. E. Engels, and S. M. Sawyer
Asthma-specific Predictors of Smoking Onset in Adolescents with Asthma: A Longitudinal Study
J. Pediatr. Psychol.,
March 1, 2009;
34(2):
118 - 128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. P Currie, J G. Douglas, and L. G Heaney
Difficult to treat asthma in adults
BMJ,
February 24, 2009;
338(feb24_1):
b494 - b494.
[Full Text]
|
 |
|

|
 |

|
 |
 
N. J. Trimble, F. M. Botelho, C. M. T. Bauer, R. Fattouh, and M. R. Stampfli
Adjuvant and Anti-Inflammatory Properties of Cigarette Smoke in Murine Allergic Airway Inflammation
Am. J. Respir. Cell Mol. Biol.,
January 1, 2009;
40(1):
38 - 46.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Glader, B. Eldh, S. Bozinovski, K. Andelid, M. Sjostrand, C. Malmhall, G. P. Anderson, G. C. Riise, I. Qvarfordt, and A. Linden
Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space
Eur. Respir. J.,
September 1, 2008;
32(3):
644 - 650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bjermer
Review: Evaluating combination therapies for asthma: pros, cons, and comparative benefits
Therapeutic Advances in Respiratory Disease,
June 1, 2008;
2(3):
149 - 161.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Braganza, R. Chaudhuri, and N. C. Thomson
Review: Treating patients with respiratory disease who smoke
Therapeutic Advances in Respiratory Disease,
April 1, 2008;
2(2):
95 - 107.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Osborne, K. L. Pedula, M. O'Hollaren, K. M. Ettinger, T. Stibolt, A. S. Buist, and W. M. Vollmer
Assessing Future Need for Acute Care in Adult Asthmatics: The Profile of Asthma Risk Study: A Prospective Health Maintenance Organization-Based Study
Chest,
October 1, 2007;
132(4):
1151 - 1161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tsoumakidou, W. Elston, J. Zhu, Z. Wang, E. Gamble, N. M. Siafakas, N. C. Barnes, and P. K. Jeffery
Cigarette Smoking Alters Bronchial Mucosal Immunity in Asthma
Am. J. Respir. Crit. Care Med.,
May 1, 2007;
175(9):
919 - 925.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Thomson
Smokers with Asthma: What Are the Management Options?
Am. J. Respir. Crit. Care Med.,
April 15, 2007;
175(8):
749 - 750.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. D Pavord
Non-eosinophilic asthma and the innate immune response
Thorax,
March 1, 2007;
62(3):
193 - 194.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Tonnesen, L. Carrozzi, K. O. Fagerstrom, C. Gratziou, C. Jimenez-Ruiz, S. Nardini, G. Viegi, C. Lazzaro, I. A. Campell, E. Dagli, et al.
Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy
Eur. Respir. J.,
February 1, 2007;
29(2):
390 - 417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Livingston, R. Chaudhuri, A. D. McMahon, I. Fraser, C. P. McSharry, and N. C. Thomson
Systemic sensitivity to corticosteroids in smokers with asthma
Eur. Respir. J.,
January 1, 2007;
29(1):
64 - 71.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sjaheim, J. Kongerud, O. Bjortuft, P. A. Drablos, D. Malterud, and T. S. Halstensen
Reduced bronchial CD4+ T-cell density in smokers with occupational asthma
Eur. Respir. J.,
December 1, 2006;
28(6):
1138 - 1144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Chanez and P. Godard
Is difficult asthma still clinically meaningful?
Eur. Respir. J.,
November 1, 2006;
28(5):
897 - 899.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P A B Wark and P G Gibson
Asthma exacerbations {middle dot} 3: Pathogenesis.
Thorax,
October 1, 2006;
61(10):
909 - 915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes
Against the dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases.
Am. J. Respir. Crit. Care Med.,
August 1, 2006;
174(3):
240 - 243.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Hothersall, C McSharry, and N C Thomson
Potential therapeutic role for statins in respiratory disease.
Thorax,
August 1, 2006;
61(8):
729 - 734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Chaudhuri, E. Livingston, A. D. McMahon, J. Lafferty, I. Fraser, M. Spears, C. P. McSharry, and N. C. Thomson
Effects of Smoking Cessation on Lung Function and Airway Inflammation in Smokers with Asthma
Am. J. Respir. Crit. Care Med.,
July 15, 2006;
174(2):
127 - 133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes
Reduced Histone Deacetylase in COPD: Clinical Implications
Chest,
January 1, 2006;
129(1):
151 - 155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-P. Boulet
Future Directions in the Clinical Management of Cough: ACCP Evidence-Based Clinical Practice Guidelines
Chest,
January 1, 2006;
129(1_suppl):
287S - 292S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Robbins, M. A. Pouladi, R. Fattouh, D. E. Dawe, N. Vujicic, C. D. Richards, M. Jordana, M. D. Inman, and M. R. Stampfli
Mainstream Cigarette Smoke Exposure Attenuates Airway Immune Inflammatory Responses to Surrogate and Common Environmental Allergens in Mice, Despite Evidence of Increased Systemic Sensitization
J. Immunol.,
September 1, 2005;
175(5):
2834 - 2842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J E M Tomlinson, A D McMahon, R Chaudhuri, J M Thompson, S F Wood, and N C Thomson
Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma
Thorax,
April 1, 2005;
60(4):
282 - 287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sandstrom and B. Lundback
Tobacco smoke: old foe more important for asthma than commonly appreciated?
Eur. Respir. J.,
November 1, 2004;
24(5):
720 - 721.
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the European Respiratory Society.
|
|